BEST SCIENCE FOR THE MOST NEGLECTED: Epichem is excited to announce that our partnership with the Drugs for Neglected Diseases Initiative, DNDi, to develop life-saving medicines for people with neglected diseases around the world, will continue in 2022.

The contract renewal will see Epichem continue to provide its synthetic and medicinal chemistry expertise to support DNDi’s drug discovery projects.

This will mark the 14th consecutive year with DNDi, supporting their important work and Epichem looks forward to continuing a long-standing and important relationship with them.”

https://dndi.org/